Effect of siRNAs on HSV-1 plaque formation and relative expression levels of RR mRNA
- PMID: 21331889
- PMCID: PMC8222430
- DOI: 10.1007/s12250-011-3162-9
Effect of siRNAs on HSV-1 plaque formation and relative expression levels of RR mRNA
Abstract
RNA interference (RNAi) is a process by which introduced small interfering RNA (siRNA) can cause the specific degradation of mRNA with identical sequences. The human herpes simplex virus type 1 (HSV-1) RR is composed of two distinct homodimeric subunits encoded by UL39 and UL40, respectively. In this study, we applied siRNAs targeting the UL39 and UL40 genes of HSV-1. We showed that synthetic siRNA silenced effectively and specifically UL39 and UL40 mRNA expression and inhibited HSV-1 replication. Our work offers new possibilities for RNAi as a genetic tool for inhibition of HSV-1 replication.
Similar articles
-
RNA interference inhibits herpes simplex virus type 1 isolated from saliva samples and mucocutaneous lesions.Braz J Infect Dis. 2014 Jul-Aug;18(4):441-4. doi: 10.1016/j.bjid.2014.01.011. Epub 2014 May 15. Braz J Infect Dis. 2014. PMID: 24835621 Free PMC article.
-
Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA.Arch Virol. 2008;153(7):1401-6. doi: 10.1007/s00705-008-0110-1. Epub 2008 Jun 13. Arch Virol. 2008. PMID: 18551244
-
Inhibition of herpes simplex virus type 1 by small interfering RNA.Clin Exp Dermatol. 2008 Jan;33(1):56-61. doi: 10.1111/j.1365-2230.2007.02543.x. Epub 2007 Nov 2. Clin Exp Dermatol. 2008. PMID: 17979991 Free PMC article.
-
Interfering with hepatitis C virus RNA replication.Virus Res. 2004 Jun 1;102(1):19-25. doi: 10.1016/j.virusres.2004.01.011. Virus Res. 2004. PMID: 15068876 Review.
-
Herpes simplex virus type-1: a model for genome transactions.Prog Nucleic Acid Res Mol Biol. 2003;75:139-71. doi: 10.1016/s0079-6603(03)75005-3. Prog Nucleic Acid Res Mol Biol. 2003. PMID: 14604012 Review.
Cited by
-
The identification of viral ribonucleotide reductase encoded by ORF23 and ORF141 genes and effect on CyHV-2 replication.Front Microbiol. 2023 Apr 18;14:1154840. doi: 10.3389/fmicb.2023.1154840. eCollection 2023. Front Microbiol. 2023. PMID: 37143536 Free PMC article.
-
Developing oncolytic Herpes simplex virus type 1 through UL39 knockout by CRISPR-Cas9.Iran J Basic Med Sci. 2020 Jul;23(7):937-944. doi: 10.22038/ijbms.2020.43864.10286. Iran J Basic Med Sci. 2020. PMID: 32774817 Free PMC article.
-
CRISPR/Cas9 Eye Drop HSV-1 Treatment Reduces Brain Viral Load: A Novel Application to Prevent Neuronal Damage.Pathogens. 2024 Dec 10;13(12):1087. doi: 10.3390/pathogens13121087. Pathogens. 2024. PMID: 39770347 Free PMC article.
-
Adenovirus-mediated shRNA interference against HSV-1 replication in vitro.J Neurovirol. 2016 Dec;22(6):799-807. doi: 10.1007/s13365-016-0453-4. Epub 2016 Aug 26. J Neurovirol. 2016. PMID: 27566181
-
RNA interference inhibits herpes simplex virus type 1 isolated from saliva samples and mucocutaneous lesions.Braz J Infect Dis. 2014 Jul-Aug;18(4):441-4. doi: 10.1016/j.bjid.2014.01.011. Epub 2014 May 15. Braz J Infect Dis. 2014. PMID: 24835621 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources